《內地樓市》民行(01988.HK)與第二批共12家房企簽全面戰略合作協議
據《中國證券網》從民生銀行(01988.HK)(600016.SH)獲悉,其分別與電建地產、大悅城控股、五礦地產、華發股份、首創城發、聯發集團、遠洋集團、卓越集團、復地集團、華宇集團、中駿集團及京基地產簽署全面戰略合作協議。這是繼12月8日與首批10家房企簽訂戰略合作協議之後,民行與第二批12家房企實現簽約。
根據合作協議,民行將圍繞商品房、保障房、綠色建築、城市更新等重點領域,為該12家房企提供多元化綜合金融服務,在房地產開發貸款、個人住房按揭貸款、併購貸款、預售資金保函、保障性租賃住房貸款、資產證券化、債券承銷與投資、支付結算等業務層面開展合作。(ta/s) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.